Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00499863 · ClinicalTrials.gov registry record · Phase 3
Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
A Phase 3 study of ADHD, sponsored by Noven Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 217
- Enrollment target
- 20
- Study locations
NCT00499863 is a Phase 3 study of ADHD that has completed, run by Noven Therapeutics. The registered enrollment target is 217 participants, above the 187-participant average among 75 other ADHD trials with a reported enrollment target (16% higher). The trial reports 20 study locations across 14 states.
The verdict
NCT00499863, a Phase 3 study of ADHD, has completed, sponsored by Noven Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 217 participants
- Enrollment target
- 20
- Study locations
Study Summary
To assess the efficacy and safety of efficacy of MTS compared to placebo
Conditions Studied
Interventions
- DRUG Placebo
- DRUG methylphenidate transdermal system
Study Locations (20)
California
- Bay Area Research Institute - Lafayette
- Elite Clinical Trials Inc. - Wildomar
Florida
- Sarkis Clinical Trials - Gainesville
- Miami Research Associates - South Miami
Kentucky
- Shire Clinical Research Site - Lexington
- Four Rivers Clinical Research, Inc. - Paducah
Michigan
- Rochester Center for Behavioral Medicine - Rochester Hills
- Clinical Neurophysiology Services, PC - Troy
North Dakota
- Dakota Clinic/Innovis health - Fargo
- Odyssey Research - Minot
Oregon
- Oregon Center for Clinical Investigations, Inc. - Eugene
- OCCI, Inc - Portland
Arizona
- Melmed Center - Scottsdale
Georgia
- Northwest Behavioral Research Ctr - Roswell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00499863
The ClinicalTrials.gov registry entry for NCT00499863 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 217 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 187-participant average among 75 other ADHD trials with a reported enrollment target (16% higher). The listed sponsor is Noven Therapeutics, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00499863 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Florida, Kentucky.
Frequently Asked Questions
What is clinical trial NCT00499863 about?
NCT00499863 is a clinical study titled "Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD". To assess the efficacy and safety of efficacy of MTS compared to placebo
What is the current status of trial NCT00499863?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 217 participants. The study started on 2007-07. Estimated completion is 2008-05.
What conditions does trial NCT00499863 study?
This clinical trial studies the following conditions: ADHD.
What interventions are being tested in trial NCT00499863?
The interventions under investigation include: Placebo (DRUG), methylphenidate transdermal system (DRUG).
Who is sponsoring clinical trial NCT00499863?
This trial is sponsored by Noven Therapeutics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00499863 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
RECRUITING · Phase 3
-
Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial
ACTIVE NOT RECRUITING · Phase 3
-
Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
COMPLETED · Phase 3
-
Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD
COMPLETED · Phase 3
-
Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD
COMPLETED · Phase 3
-
PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.